|
|
Post by Omega on Sept 19, 2017 12:48:57 GMT -5
Picked up another 1,100 shares at $2.07
|
|
|
|
Post by kite on Sept 19, 2017 12:59:23 GMT -5
Picked up another 1,100 shares at $2.07 I think I'm going to test my patience with the price drop a little longer in order to decrease my buy-in position |
|
|
|
Post by peppy on Sept 19, 2017 15:08:35 GMT -5
MNKD real time nasdaq volume today, 3,085,176 shares. 3% of shares outstanding. $2.02. down 26 cents down 11.4% www.nasdaq.com/symbol/mnkd/real-time
MNKD Nasdaq summation volume, 4,122,902 shares. www.nasdaq.com/symbol/mnkd
trading took out most of last weeks gains. the 200 day sma $1.96 and the 20 day $1.91 below
a daily with exponential moving averages schrts.co/iPmh3e the 200 day ema $2.22 the 20 day ema $1.94
|
|
|
|
Post by brotherm1 on Sept 19, 2017 15:44:36 GMT -5
It appears the 11 cent triangle set up was superseded by the ole -26 cent wrecktangle. 😢 |
|
|
|
Post by peppy on Sept 19, 2017 15:48:25 GMT -5
It appears the 11 cent triangle set up was superseded by the ole -26 cent wrecktangle. 😢 yes, brotherm, they break both ways. 
|
|
|
|
Volume too
Sept 19, 2017 23:02:52 GMT -5
via mobile
Post by straightly on Sept 19, 2017 23:02:52 GMT -5
It appears the 11 cent triangle set up was superseded by the ole -26 cent wrecktangle. 😢 yes, brotherm, they break both ways.
The sad face says this is not good. But it seemed to me the 2.00 support is there, isn't it? |
|
|
|
Post by peppy on Sept 19, 2017 23:12:00 GMT -5
yes, brotherm, they break both ways.
The sad face says this is not good. But it seemed to me the 2.00 support is there, isn't it? should be, I hope so. the 200 day sma and 20 day sma are at $1.96 and $1.91 respectively. let's hope it is a test of the 200 day sma. the 200 day ema was the resistance at $2.22.
|
|
|
|
Post by peppy on Sept 20, 2017 9:32:48 GMT -5
MNKD nasdaq real time volume, 827,077 shares in one hour.
relatively high volume.
$2.03 plus 1 cent
www.nasdaq.com/symbol/mnkd/real-time
924,925 shares in an hour and 1/2. $2.05 plus 3 cents. the 2012 lows.
price has to push this $2.05, $2.10 .
1 hour and 53 mins, 1 million shares hit 1,005,169 shares, $2.06 plus 4 cents
|
|
|
|
Post by alethea on Sept 20, 2017 10:35:05 GMT -5
Any news about what caused this sell-off? (other than just being over-bought)? I think I'm going to grab some while it's cheap, too. I don't expect this price to last long. Same ole, same ole CROOKED MANIPULATION. |
|
|
|
Post by promann on Sept 20, 2017 10:42:21 GMT -5
I think a lot of the loose leaves were shook off the tree to create a covering opportunity. Manipulation at its best. The return buying volume tells me the support is there and I think we will be looking god by the end of the week hopefully we get good script numbers breaking 400 total and new approved label next week 😄😄
|
|
|
|
Post by joeypotsandpans on Sept 20, 2017 10:52:37 GMT -5
I think a lot of the loose leaves were shook off the tree to create a covering opportunity. Manipulation at its best. The return buying volume tells me the support is there and I think we will be looking god by the end of the week hopefully we get good script numbers breaking 400 total and new approved label next week 😄😄  |
|
|
|
Post by dreamboatcruise on Sept 20, 2017 11:05:34 GMT -5
I think a lot of the loose leaves were shook off the tree to create a covering opportunity. Manipulation at its best. The return buying volume tells me the support is there and I think we will be looking god by the end of the week hopefully we get good script numbers breaking 400 total and new approved label next week 😄😄 I think we might get to 400 TRx next week, but meaning the week scripts actually occur, so not showing up until reported on Oct 6. That's based on looking at the dip that occurred this time of year in 2015. |
|
|
|
Post by promann on Sept 20, 2017 11:14:19 GMT -5
I think a lot of the loose leaves were shook off the tree to create a covering opportunity. Manipulation at its best. The return buying volume tells me the support is there and I think we will be looking god by the end of the week hopefully we get good script numbers breaking 400 total and new approved label next week 😄😄 I think we might get to 400 TRx next week, but meaning the week scripts actually occur, so not showing up until reported on Oct 6. That's based on looking at the dip that occurred this time of year in 2015. Can't go by that at all. Sanofi was running things and by this time in 2015 they probably already knew they were going to return Afrezza to MNKD. You can see on the graphs where the sales peaked and started to drop before this time in 2015 because they quit trying to sell the drug. i hope your wrong but we shall see. |
|
|
|
Post by peppy on Sept 20, 2017 11:34:07 GMT -5
I think we might get to 400 TRx next week, but meaning the week scripts actually occur, so not showing up until reported on Oct 6. That's based on looking at the dip that occurred this time of year in 2015. Can't go by that at all. Sanofi was running things and by this time in 2015 they probably already knew they were going to return Afrezza to MNKD. You can see on the graphs where the sales peaked and started to drop before this time in 2015 because they quit trying to sell the drug. i hope your wrong but we shall see. Inappropriately, can you image a conversation, that of course/coarse never took place? Sanofi, Lilly, and Novo Nordisk in a room. "We have a new insulin coming on the market, it is inhaled. The thing about this insulin is it enters the blood stream immediately through the alveoli." "What would that mean for blood glucose control?" "It may be a better blood glucose management tool than the delivery system our businesses are set up on." "It will effect our profit centers if this medication succeeds." "What are the chances it will succeed?" "Perhaps we should nip this flower at the bud? Protect our profits." "How would we do that?" money to work with. "This medication has no formulary status, and the company doesn't have much money to work with. They are looking for a partner." "One of us could partner with them and then we would have control." "That isn't a bad idea." "To be fair, we need to draw straws." The straws are brought out and drawn. Sanofi drew the short straw. "We know how to do this, we have the exubera model." "Enough said. Good work gentlemen."
I am so inappropriate.
|
|
|
|
Post by dreamboatcruise on Sept 20, 2017 11:47:09 GMT -5
I think we might get to 400 TRx next week, but meaning the week scripts actually occur, so not showing up until reported on Oct 6. That's based on looking at the dip that occurred this time of year in 2015. Can't go by that at all. Sanofi was running things and by this time in 2015 they probably already knew they were going to return Afrezza to MNKD. You can see on the graphs where the sales peaked and started to drop before this time in 2015 because they quit trying to sell the drug. i hope your wrong but we shall see. We must not be looking at the same charts. The one I see here on proboards shows a dip (especially noticeable in NRx) starting July 2015 and lasting through 2nd half Sept (note below). Then there is a recovery and the all time peak for Sanofi occurred late in Oct. In another thread someone (forgotten who, sorry) mentioned they had seen this seasonal pattern in other drug script numbers. I'm hoping I'm correct because it would mean we could be in for a nice surge once the seasonal effect is gone. If there isn't a seasonal effect then the past few weeks have been pretty darn disappointing given that we've now had our TV commercial running (limited as it is). Certainly we are not on track to meet managements projections for 2H17 on the trajectory of the past month. All that said, I wrote my previous comment based on a quick look at the graph... and my lining up of peaks and dates doesn't seem to have been accurate. Going to the actual data I see that the jump in NRx really started 9/18/15, so I'll revise my prediction. Based on that, perhaps we do get 400 occurring this week and reported next week. But if not then, hopefully a sure thing by the following week. |
|
